N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide

C43H49N9O6 — CID 167375670

IUPACN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C3CCN(CC4CCC(n5cc6cc(NC(=O)c7ccccn7)c(OC[C@H]7CCC(=O)N7)cc6n5)CC4)CC3)c21
InChIInChI=1S/C43H49N9O6/c1-49-40-31(5-4-7-35(40)52(43(49)57)36-13-15-39(54)47-42(36)56)27-16-19-50(20-17-27)23-26-8-11-30(12-9-26)51-24-28-21-34(46-41(55)32-6-2-3-18-44-32)37(22-33(28)48-51)58-25-29-10-14-38(53)45-29/h2-7,18,21-22,24,26-27,29-30,36H,8-17,19-20,23,25H2,1H3,(H,45,53)(H,46,55)(H,47,54,56)/t26?,29-,30?,36?/m1/s1
InChIKeyAVTPLJBPFAGLAB-FCGHOWGJSA-N
MW787.92 g/mol
LogP4.58
Rot. Bonds10

About N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide

N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide (PubChem CID 167375670) has the molecular formula C43H49N9O6 and a molecular weight of 787.92 g/mol. Its IUPAC name is N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide
PubChem CID167375670
Molecular FormulaC43H49N9O6
Molecular Weight787.92 g/mol
Exact Mass787.38
IUPAC NameN-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide
SMILESCn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C3CCN(CC4CCC(n5cc6cc(NC(=O)c7ccccn7)c(OC[C@H]7CCC(=O)N7)cc6n5)CC4)CC3)c21
InChIInChI=1S/C43H49N9O6/c1-49-40-31(5-4-7-35(40)52(43(49)57)36-13-15-39(54)47-42(36)56)27-16-19-50(20-17-27)23-26-8-11-30(12-9-26)51-24-28-21-34(46-41(55)32-6-2-3-18-44-32)37(22-33(28)48-51)58-25-29-10-14-38(53)45-29/h2-7,18,21-22,24,26-27,29-30,36H,8-17,19-20,23,25H2,1H3,(H,45,53)(H,46,55)(H,47,54,56)/t26?,29-,30?,36?/m1/s1
InChIKeyAVTPLJBPFAGLAB-FCGHOWGJSA-N
XLogP4.58
TPSA174.48 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500787.92
LogP ≤ 54.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide?
The IUPAC name of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide (CID 167375670) is N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide.
What is the SMILES notation for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide?
The canonical SMILES for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide is Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(C3CCN(CC4CCC(n5cc6cc(NC(=O)c7ccccn7)c(OC[C@H]7CCC(=O)N7)cc6n5)CC4)CC3)c21.
What is the InChIKey of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide?
The InChIKey is AVTPLJBPFAGLAB-FCGHOWGJSA-N. The full InChI is InChI=1S/C43H49N9O6/c1-49-40-31(5-4-7-35(40)52(43(49)57)36-13-15-39(54)47-42(36)56)27-16-19-50(20-17-27)23-26-8-11-30(12-9-26)51-24-28-21-34(46-41(55)32-6-2-3-18-44-32)37(22-33(28)48-51)58-25-29-10-14-38(53)45-29/h2-7,18,21-22,24,26-27,29-30,36H,8-17,19-20,23,25H2,1H3,(H,45,53)(H,46,55)(H,47,54,56)/t26?,29-,30?,36?/m1/s1.
What are the key properties of N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide?
N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide has a molecular weight of 787.92 g/mol, XLogP of 4.58, 10 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]cyclohexyl]-6-[[(2R)-5-oxopyrrolidin-2-yl]methoxy]indazol-5-yl]pyridine-2-carboxamide is sourced from PubChem (CID 167375670), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).